TrialJournal of Parkinson's disease2017

Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.

Camille B Carroll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.